How much cyber liability does a CRO handling PHI typically carry?

Clinical CROs handle protected health information at multiple touchpoints: subject enrollment data, source documents from clinical sites, laboratory and imaging results, electronic data capture (EDC) systems, and adverse-event reporting. The volume of PHI handled by a single Phase III oncology CRO can exceed that of mid-sized community hospitals.

Beyond PHI, CROs handle sponsor-confidential data — investigational product information, protocol details, clinical strategy. This is not HIPAA-regulated but is contractually critical and produces real economic-loss exposure if breached.

Most clinical CROs in the $10M-$100M revenue range carry $3M-$10M cyber liability. Within that range, key sizing factors are: (1) number of active subjects in trials at any given time, (2) sensitivity of the indication area (oncology and psychiatric data are higher-severity than general medical), (3) sponsor-required minimums in master services agreements (sometimes $5M, occasionally $10M), (4) jurisdictional exposure (EU subjects raise GDPR breach exposure), and (5) prior breach history.

Diagnostic and bioanalytical labs serving CROs often need higher cyber limits because PHI exposure is structurally larger (more subjects per service contract). $5M-$25M is typical for established diagnostic labs.

A complete cyber policy for a CRO includes: (1) notification expense (cost of notifying affected individuals after a breach), (2) credit monitoring and identity restoration for affected individuals, (3) regulatory defense for HIPAA, state AG, and EU GDPR proceedings, (4) regulatory fines and penalties where insurable, (5) ransomware coverage including ransom payment and business interruption, (6) social engineering coverage for fraudulent fund transfer, (7) media liability for inadvertent public disclosure, and (8) network security liability for third-party claims arising from a breach.

Sub-limits within these components matter. A $5M cyber policy with a $250K sub-limit on regulatory fines is not equivalent to a $5M cyber policy with full-policy-limit regulatory coverage. CRO buyers should review sub-limits with the broker before binding.

Most pharma sponsor MSAs now require explicit cyber coverage. Common requirements include $5M minimum limit, named additional insured for the sponsor, primary and non-contributory wording (where allowed by the cyber policy), and explicit coverage for HIPAA and sponsor-data breaches.

Some sponsors also require third-party breach notification cooperation, defined breach response procedures, and SOC 2 Type II certification as a contractual baseline. Insurance is one element of the sponsor's vendor risk framework; security posture is the other.

CROs operating in Texas should account for Texas HB 300 (Medical Records Privacy Act) in addition to HIPAA. HB 300 includes notification requirements that overlap with but are not identical to HIPAA, and Texas Attorney General enforcement has been active in healthcare data breach matters. Cyber policies written for Texas operators should explicitly cover HB 300 regulatory defense and fines where insurable.